This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

First Case In VISIUS Surgical Theatre At Florida Hospital

Intraoperative Imaging System at the Heart of New Neurosurgical Suite

WINNIPEG, Jan. 31, 2012 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported on the first neurosurgical case that was performed in the new VISIUS Surgical Theatre at Florida Hospital in Orlando, Fla. Dr. Melvin Field, Director of the Florida Hospital Minimally Invasive Brain Surgery Program and Surgical Director of the Florida Hospital Neuroscience Institute, performed the case on December 19, 2011 involving a resection of a pituitary tumor in an adult patient. The intraoperative MR images taken before completing the procedure confirmed that the entire tumor had been removed as planned. Afterwards, Dr. Field commented: "While we have been able to treat these tumors before, the intraoperative technology allowed us to confirm that we had fully removed the entire tumor before ending surgery, eliminating the need for post-operative repeat imaging or reoperation." He continued: "We were also able to inform the patient's family of the surgery's complete success before they even went in to see him."

"Getting it all out" is a primary patient concern when it comes to brain tumor treatment.  According to research at the University of California in San Francisco in 2007, improved outcomes among adult patients with certain kinds of aggressive tumors is predicted by greater extent of resection.  A study published by Barnes-Jewish Hospital in 2011 showed that using intraoperative MR imaging during tumor resection, surgeons achieved gross total resection in 93% of their patients, compared to achieving gross total resection in only 65% of their patients when intraoperative MR was not used.

Located within Florida Hospital Orlando's new 35,000 square-foot neurosurgery center, the VISIUS Surgical Theatre features two state-of-the-art operating rooms connected by a room used for diagnostic imaging and a ceiling-mounted MR scanner that moves between all three rooms.  The larger of the two ORs, called InnovatOR, is a surgical center in which clinical staff and industry partners will co-develop products, techniques and processes to improve patient outcomes and increase clinician efficiency.  Unique to the VISIUS Surgical Theatre is the first removable MR-compatible operating table, which can be completely removed from the operating room to allow surgeons to perform procedures that require a specific surgical table.

Eric Stevens, Vice President of Operations at Florida Hospital Orlando, comments: "Our initial success is very encouraging.  The intraoperative imaging capability of the VISIUS Surgical Theatre is central to our strategy to improve patient outcomes in neurosurgery by combining innovative technologies and partnering with medical industry leaders like IMRIS."

About Florida Hospital Neuroscience Institute

The Florida Hospital Neuroscience Institute (NSI) treats more neurology patients than any other hospital in the nation and features the largest neurosurgery program in Florida. As leader in brain and spine disorders, NSI includes more than 80 physicians providing multidisciplinary care through comprehensive programs in neurosurgery, interventional neuroradiology, neuro-oncology, neurodiagnostics and stroke and spine centers

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.

SOURCE IMRIS Inc.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs